|
Oct 17
|
Avacta Expands its Pipeline with Two Novel Assets Developed Using its pre|CISION® Platform
|
|
Oct 15
|
Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer
|
|
Oct 10
|
Avacta to Unveil Pipeline Expansion and Novel, Next-Generational Targeted Cancer Therapy Programs at 2024 EORTC-NCI-AACR Symposium
|
|
Apr 5
|
Avacta Group - AVA6000 Abstract Release by AACR and Full Presentation Update
|
|
Dec 19
|
Appointment of Chief Business Officer
|
|
Nov 30
|
Levicept Appoints Eliot Forster as CEO
|